Insys Therapeutics, Inc.
(NASDAQ : INSY)

( )
INSY PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.73%193.481.2%$597.74m
GILDGilead Sciences, Inc.
-0.02%68.000.9%$503.14m
CELGCelgene Corporation
-0.92%68.761.2%$488.79m
BIIBBiogen Inc.
-0.69%317.001.3%$464.36m
ILMNIllumina, Inc.
-1.15%298.113.5%$377.30m
REGNRegeneron Pharmaceuticals, Inc.
0.00%339.002.6%$298.68m
VRTXVertex Pharmaceuticals Incorporated
-2.45%161.071.9%$260.54m
ALXNAlexion Pharmaceuticals, Inc.
-3.00%115.062.0%$199.08m
AAgilent Technologies, Inc.
-3.72%62.571.5%$185.86m
SRPTSarepta Therapeutics, Inc.
-2.25%116.3615.4%$146.77m
LGNDLigand Pharmaceuticals Incorporated
-3.83%148.5423.3%$139.57m
EXASExact Sciences Corporation
0.00%67.2825.3%$137.02m
NKTRNektar Therapeutics
-2.11%37.215.6%$119.67m
INCYIncyte Corporation
-3.40%64.252.5%$115.74m
TSROTESARO, Inc.
-1.22%36.3814.4%$108.05m

Company Profile

INSYS Therapeutics, Inc. is a c pharmaceutical company, which develops and commercializes supportive care products. It focuses on utilizing commercial pharmaceutical products. Its products include Subsys, a proprietary sublingual fentanyl spray for BTCP in opioid-tolerant adult patients; and Syndros, a proprietary, orally administered liquid formulation of dronabinol for the treatment of CINV and anorexia associated with weight loss in patients with AIDS. The company was founded by John N. Kapoor on June 15, 1990 and is headquartered in Chandler, AZ.